RT @daniellesacks: The definitive story of how Hims found itself in the crosshairs of Big pharma, MAHA, short sellers, regulators, meme-sto….

RT @devinleonard: Teamed up again with my colleague,@g0ingmad, this time to chronicle the career and controversies of Hims & Hers CEO Andre….

(And here’s a 🎁 link!)

In recent months, Hims has been the topic of fervid conversation, disdain and intrigue among any number of groups—pharma companies, short sellers, meme-stock investors, and, of course, those trying to find an affordable way to shed a few pounds. For @BW .

RT @business: US ice cream makers are planning to eliminate a number of artificial colors from their products by 2028 .

RT @AmberTongPW: Chinese drugmakers have come a long way from their copycat days to challenge Western dominance on innovation. Our latest….

RT @amandamull: This month’s Businessweek cover story is out, and it’s me and Lily Meier on whether, after decades of declining sales and f….

Grocery shopping after making my trip to Iceland last week my entire personality

RT @business: Hims & Hers Health won’t back down from selling cheap weight-loss shots, its CEO said after Novo Nordisk abruptly ended its d….

NEW: Hims won’t back down from selling copycat weight-loss shots after Novo Nordisk abruptly ended its distribution partnership. “There’s just no way in hell we’re going to cave on that," CEO @AndrewDudum told @business. More here from me + @devinleonard:.

Scenes from @AmDiabetesAssn in Chicago, where the booths this year are bigger, brighter and more high-tech than ever

RT @leilei_wuu: Lilly's top oncology execs: If a cancer program needs a mid-stage trial, its too mid for Lilly. My look at Lilly's cancer….

New: Hims is cutting more than 4% of its workforce. “While not easy, this step reflects our commitment to invest in the areas that will define our future,” a spokesperson told me. More here for @business⬇️.

RT @gerryfsmith: US health officials are terminating a contract with Moderna worth up to $766 million to develop vaccines for bird flu. Sto….

New: The ouster of Lars Fruergaard Jorgensen — only the fifth CEO in Novo’s century-long history — marks a turning point in the race to dominate the pharmaceutical industry’s hottest market. More from me and @naomikresge here: ⬇️.

“If they’re available at the pharmacy, people assume they’re overseen by the FDA, but unfortunately, in the case of these unapproved drugs, they aren’t.”. Read the latest from @annaedney ⬇️⬇️. .

“This is the first event where I haven’t fought with the audience,” @calleymeans tells @maxonwifi 🤣

Listening to @maxonwifi talk ADCs with GSK and BioNTech 👨‍🔬🧬

RT @ShelbyJLiv: NEW: Empower Pharmacy, which calls itself the US’ “largest and most advanced” compounding pharmacy has used poor-quality i….

Extremely humbled to be named a @NIHCMfoundation Investigative & General reporting finalist for our reporting on Ozempictown, USA! @devinleonard @tanaz115.